JP6985367B2 - 新規化合物および方法 - Google Patents
新規化合物および方法 Download PDFInfo
- Publication number
- JP6985367B2 JP6985367B2 JP2019503748A JP2019503748A JP6985367B2 JP 6985367 B2 JP6985367 B2 JP 6985367B2 JP 2019503748 A JP2019503748 A JP 2019503748A JP 2019503748 A JP2019503748 A JP 2019503748A JP 6985367 B2 JP6985367 B2 JP 6985367B2
- Authority
- JP
- Japan
- Prior art keywords
- formula
- compound
- hydrogen
- reaction
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 0 C[Al](*)N=C(C(*)=C(c1c2*)N3C(*)*c1c(*)c(OI)c2O*)N(CC#N)C3=O Chemical compound C[Al](*)N=C(C(*)=C(c1c2*)N3C(*)*c1c(*)c(OI)c2O*)N(CC#N)C3=O 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1613054.4 | 2016-07-28 | ||
| GBGB1613054.4A GB201613054D0 (en) | 2016-07-28 | 2016-07-28 | New compound and process |
| PCT/GB2017/052190 WO2018020249A1 (en) | 2016-07-28 | 2017-07-27 | New compound and process |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019527228A JP2019527228A (ja) | 2019-09-26 |
| JP2019527228A5 JP2019527228A5 (https=) | 2021-06-17 |
| JP6985367B2 true JP6985367B2 (ja) | 2021-12-22 |
Family
ID=56936838
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019503748A Active JP6985367B2 (ja) | 2016-07-28 | 2017-07-27 | 新規化合物および方法 |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US10710998B2 (https=) |
| EP (1) | EP3490988B1 (https=) |
| JP (1) | JP6985367B2 (https=) |
| KR (1) | KR102396059B1 (https=) |
| CN (1) | CN109641891B (https=) |
| CY (1) | CY1122138T1 (https=) |
| DK (1) | DK3490988T3 (https=) |
| ES (1) | ES2751948T3 (https=) |
| GB (1) | GB201613054D0 (https=) |
| HR (1) | HRP20192109T1 (https=) |
| HU (1) | HUE046509T2 (https=) |
| LT (1) | LT3490988T (https=) |
| PL (1) | PL3490988T3 (https=) |
| PT (1) | PT3490988T (https=) |
| RS (1) | RS59566B1 (https=) |
| SI (1) | SI3490988T1 (https=) |
| SM (1) | SMT201900582T1 (https=) |
| TW (1) | TWI739871B (https=) |
| WO (1) | WO2018020249A1 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL3231444T3 (pl) | 2014-05-12 | 2020-05-18 | Verona Pharma Plc | Nowe leczenie |
| GB201502260D0 (en) | 2015-02-11 | 2015-04-01 | Verona Pharma Plc | Salt of Pyrimido[6,1-A]Isoquinolin-4-one compound |
| HRP20251132T1 (hr) * | 2020-01-17 | 2025-11-21 | Lupin Limited | Postupci, procesi i međuproizvodi za pripremu spojeva kromana |
| CN116917287A (zh) | 2021-04-29 | 2023-10-20 | 苏州盛迪亚生物医药有限公司 | 异喹啉酮类化合物及其用途 |
| TW202325301A (zh) * | 2021-12-14 | 2023-07-01 | 大陸商海思科醫藥集團股份有限公司 | 三環稠雜環類pde3/4雙重抑制及其用途 |
| GB202202297D0 (en) | 2022-02-21 | 2022-04-06 | Verona Pharma Plc | Formulation production process |
| EP4378942A1 (en) | 2022-12-02 | 2024-06-05 | Sandoz AG | Crystal form of a pde3/4 inhibitor |
| WO2025003643A1 (en) | 2023-06-26 | 2025-01-02 | Verona Pharma Plc | Particulate composition comprising ensifetrine |
| AU2024309346C1 (en) | 2023-06-26 | 2026-03-12 | Verona Pharma Plc | Particulate composition comprising ensifentrine |
| WO2025052119A1 (en) | 2023-09-06 | 2025-03-13 | Verona Pharma Plc | Ensifentrine for use in treating chronic obstructive pulmonary disease (copd) |
| US20250249008A1 (en) | 2024-02-07 | 2025-08-07 | Verona Pharma Plc | Pharmaceutical compositions of ensifentrine for chronic obstructive pulmonary disease |
| US20250249007A1 (en) | 2024-02-07 | 2025-08-07 | Verona Pharma Plc | Pharmaceutical compositions of ensifentrine for chronic obstructive pulmonary disease |
| WO2025176871A1 (en) | 2024-02-23 | 2025-08-28 | Inke, S.A. | Process for preparing pyrimido[6,1-a]isoquinoline-4-ones |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ185900A (en) | 1976-12-10 | 1981-04-24 | Hoechst Ag | Pyrimido (6,1-a) isoquinolin-4-ones medicaments intermediate isoquinolines |
| FI64370C (fi) | 1977-05-05 | 1983-11-10 | Hoechst Ag | Foerfarande foer framstaellning av terapeutiskt anvaendbara pyimido-(6,1-a)isokinolin-2-imino-4-onderivat |
| DE2847693A1 (de) | 1978-11-03 | 1980-05-22 | Hoechst Ag | Verfahren zur herstellung von pyrimido-(6,1-a)-isochinolin-2-onen |
| DE3135831A1 (de) | 1981-09-10 | 1983-04-28 | Hoechst Ag, 6230 Frankfurt | 9,10-substituierte 2-mesitylimino-3-alkyl-3,4,6,7-tetrahydro-2h-pyrimido(6,1-a)isochinolin-4-one, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
| ZW6284A1 (en) | 1983-05-05 | 1985-10-30 | Hoffmann La Roche | Novel pyrimidone derivatives |
| DE60005493T2 (de) | 1999-03-31 | 2004-07-01 | Vernalis Ltd., Wokingham | Pyrimido[6,1-a]isochinolinonderivate |
| PH12013500261A1 (en) | 2010-08-09 | 2013-03-04 | Verona Pharma Plc | Crystalline form of pyrimidio[6,1-a]isoquinolin-4-one compound |
| EP2968312B1 (en) | 2013-03-15 | 2018-01-31 | Verona Pharma PLC | Drug combination |
| PL3231444T3 (pl) | 2014-05-12 | 2020-05-18 | Verona Pharma Plc | Nowe leczenie |
| MY196072A (en) | 2014-09-15 | 2023-03-13 | Verona Pharma Plc | Liquid Inhalation Formulation Comprising RPL554 |
| GB201502260D0 (en) | 2015-02-11 | 2015-04-01 | Verona Pharma Plc | Salt of Pyrimido[6,1-A]Isoquinolin-4-one compound |
-
2016
- 2016-07-28 GB GBGB1613054.4A patent/GB201613054D0/en not_active Ceased
-
2017
- 2017-07-27 EP EP17748880.6A patent/EP3490988B1/en active Active
- 2017-07-27 SI SI201730098T patent/SI3490988T1/sl unknown
- 2017-07-27 HU HUE17748880A patent/HUE046509T2/hu unknown
- 2017-07-27 PL PL17748880T patent/PL3490988T3/pl unknown
- 2017-07-27 DK DK17748880T patent/DK3490988T3/da active
- 2017-07-27 LT LTEP17748880.6T patent/LT3490988T/lt unknown
- 2017-07-27 JP JP2019503748A patent/JP6985367B2/ja active Active
- 2017-07-27 KR KR1020197004436A patent/KR102396059B1/ko active Active
- 2017-07-27 CN CN201780046788.1A patent/CN109641891B/zh active Active
- 2017-07-27 TW TW106125312A patent/TWI739871B/zh active
- 2017-07-27 ES ES17748880T patent/ES2751948T3/es active Active
- 2017-07-27 WO PCT/GB2017/052190 patent/WO2018020249A1/en not_active Ceased
- 2017-07-27 RS RS20191474A patent/RS59566B1/sr unknown
- 2017-07-27 SM SM20190582T patent/SMT201900582T1/it unknown
- 2017-07-27 HR HRP20192109TT patent/HRP20192109T1/hr unknown
- 2017-07-27 PT PT177488806T patent/PT3490988T/pt unknown
- 2017-07-27 US US16/309,435 patent/US10710998B2/en active Active
-
2019
- 2019-10-04 CY CY20191101046T patent/CY1122138T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2019527228A (ja) | 2019-09-26 |
| RS59566B1 (sr) | 2019-12-31 |
| SI3490988T1 (sl) | 2019-11-29 |
| ES2751948T3 (es) | 2020-04-02 |
| US20190330206A1 (en) | 2019-10-31 |
| CN109641891A (zh) | 2019-04-16 |
| EP3490988B1 (en) | 2019-08-28 |
| KR20190034231A (ko) | 2019-04-01 |
| EP3490988A1 (en) | 2019-06-05 |
| SMT201900582T1 (it) | 2019-11-13 |
| DK3490988T3 (da) | 2019-10-28 |
| TWI739871B (zh) | 2021-09-21 |
| US10710998B2 (en) | 2020-07-14 |
| LT3490988T (lt) | 2019-10-10 |
| HRP20192109T1 (hr) | 2020-02-21 |
| WO2018020249A1 (en) | 2018-02-01 |
| HUE046509T2 (hu) | 2020-03-30 |
| TW201806951A (zh) | 2018-03-01 |
| CN109641891B (zh) | 2021-05-04 |
| GB201613054D0 (en) | 2016-09-14 |
| KR102396059B1 (ko) | 2022-05-10 |
| PL3490988T3 (pl) | 2020-02-28 |
| PT3490988T (pt) | 2019-10-28 |
| CY1122138T1 (el) | 2020-11-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6985367B2 (ja) | 新規化合物および方法 | |
| JP7795485B2 (ja) | ピリミジニル－３，８－ジアザビシクロ［３．２．１］オクタニルメタノン誘導体およびその塩の調製 | |
| CN101903390A (zh) | 制备西他列汀及其药学上可接受的盐的方法 | |
| JP2021500386A (ja) | リボシクリブおよびその塩の改善された調製のためのプロセス | |
| CN104159898A (zh) | 用于制备取代的5-氟-1h-吡唑并吡啶类化合物的方法 | |
| KR102684954B1 (ko) | 아미노피리미딘 유도체의 합성에 유용한 신규의 중간체, 이의 제조방법 및 이를 이용한 아미노피리미딘 유도체의 제조방법 | |
| JP7320113B2 (ja) | ヘテロシクリデンアセトアミド誘導体の製造方法 | |
| CN113767094B (zh) | 3-甲基-1,2,4-噻二唑-5-碳酰肼及其甲基-d3氘代形式的合成 | |
| KR20180038460A (ko) | 세포독성 벤조다이아제핀 유도체의 제조 방법 | |
| CN107922352A (zh) | 制备蛋白质脱乙酰酶抑制剂的方法 | |
| KR102886188B1 (ko) | 헤테로시클리덴아세트아미드 유도체의 제조 방법 | |
| EP4313987B1 (en) | Process for the preparation of ribociclib and pharmaceutically acceptable salts thereof | |
| CN113637003B (zh) | 一种制备2-氨基-6-（哌啶-4-酰基）吡啶衍生物的方法 | |
| US20250145623A1 (en) | Methods of preparation of heterocyclic compounds | |
| WO2021241725A1 (ja) | 高純度のｎ－（５－メトキシ―２－フェノキシフェニル）メタンスルホンアミド及びその製造方法 | |
| CN105849115A (zh) | 制药方法和中间体 | |
| JP6664170B2 (ja) | アミノヒドロキシピリジン化合物の製造方法 | |
| TW201625632A (zh) | Ｐｉ３ｋ抑制劑及其鹽之合成 | |
| CN113816955B (zh) | 一种ret激酶抑制剂中间体及其制备方法 | |
| WO2019064222A1 (en) | CRYSTALLINE FORMS OF LENALIDOMIDE | |
| HK40002783B (en) | New compound and process | |
| HK40002783A (en) | New compound and process | |
| KR20240038024A (ko) | B형 간염 바이러스 뉴클레오캡시드 억제제의 제조 방법 | |
| TW202610648A (zh) | 新穎的胺基羰基化製程 | |
| JP2024501494A (ja) | オシメルチニブまたはその塩を調製するための改良された方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20190207 |
|
| RD01 | Notification of change of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7426 Effective date: 20190207 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20200701 |
|
| A524 | Written submission of copy of amendment under article 19 pct |
Free format text: JAPANESE INTERMEDIATE CODE: A524 Effective date: 20210430 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20210729 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20210803 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210909 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20211116 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20211125 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 6985367 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |